METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Zapping spreading spots to keep lung cancer drugs working longer
Disease control Not yet recruitingThis study is for people with advanced lung cancer whose targeted drug therapy is starting to fail at a few specific spots in the body. It tests whether using precise, high-dose radiation on those few progressing spots can help control the cancer and allow patients to stay on the…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 04, 2026 06:51 UTC
-
Common mineral could boost cancer treatment
Disease control Not yet recruitingThis study is testing whether adding magnesium supplements to standard chemo-immunotherapy helps people with advanced non-small cell lung cancer. Magnesium is important for immune function, and chemotherapy often lowers magnesium levels. Researchers will randomly give 230 partici…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2, PHASE3 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Gentler chemo combo aims to extend life for frail lung cancer patients
Disease control Not yet recruitingThis study is for people 70 and older with advanced lung cancer who are too frail for standard chemotherapy. It compares two approaches: a lower-dose chemotherapy combined with an immunotherapy drug (cemiplimab) versus the immunotherapy drug alone. The goal is to find a treatment…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC